# Biocept Inc. (BIOC) Source: https://www.quantisnow.com/company/BIOC Generated: 2026-11-14T23:42:53.796Z - Ticker: BIOC - Exchange: NASDAQ - Sector: Health Care - Industry: Medical Specialities - IPO year: 2014 - Website: biocept.com ## About Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring in order to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreaticobiliary cancer, and ovarian cancer. Its Target-Selector molecular technology enables detection of mutations and genome alterations with enhanced sensitivity and specificity, as well as is applicable to nucleic acid from circulating tumor DNA; and Target-Selector CTC and molecular platforms provide biomarker detection and monitoring capabilities. In addition, it offers laboratory services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians. Further, it is developing PCR-based assays for detecting the COVID-19 virus. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, laboratories, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. It has a partnership with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California. ## Latest BIOC news and filings - 2023-10-24 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5035873) - 2023-10-23 17:54 UTC [Market Insight] [Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-engagesmart-shares-are-trading-higher-by-around-12-here-5032583) - 2023-10-23 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-5032067) - 2023-10-20 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-5030080) - 2023-10-20 10:06 UTC [SEC Form 8-K] [Biocept Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/biocept-inc-filed-sec-form-8-k-notice-of-delisting-or-5029668) - 2023-10-19 17:52 UTC [Market Insight] [Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-nokia-shares-are-trading-lower-by-over-5-here-5028689) - 2023-10-19 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-5028642) - 2023-10-19 11:38 UTC [Market Insight] [Why Netflix Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-netflix-shares-are-trading-higher-by-around-14-here-5027740) - 2023-10-18 18:15 UTC [Market Insight] [Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-nuvve-holding-shares-are-trading-lower-by-45-here-5026438) - 2023-10-18 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-5026386) - 2023-10-18 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-5025836) - 2023-10-18 12:18 UTC [Market Insight] [Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-talaris-therapeutics-shares-are-trading-higher-by-around-8-5025625) - 2023-10-17 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5024844) - 2023-10-16 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-5021659) - 2023-10-16 17:09 UTC [Market Insight] [Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-streamline-health-solutions-shares-are-trading-lower-by-over-5021620) - 2023-10-16 16:22 UTC [Market Insight] [Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?](https://www.quantisnow.com/insight/why-is-liquid-biopsy-firm-biocept-stock-trading-lower-today-5021536) - 2023-10-16 14:07 UTC [Market Insight] [Dow Surges Over 200 Points; Empire State Manufacturing Index Falls In October](https://www.quantisnow.com/insight/dow-surges-over-200-points-empire-state-manufacturing-index-falls-5021282) - 2023-10-16 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-5021114) - 2023-10-16 13:01 UTC [Market Chatter] [Biocept Inc Says On Oct 13th, Filed Voluntary Petition Under The Provisions Of Chapter 7 In Bankruptcy Court; Following Resignations Of Members, Company Will Have No Members Serving On Its Board Of Directors](https://www.quantisnow.com/insight/biocept-inc-says-on-oct-13th-filed-voluntary-petition-under-5021082) - 2023-10-16 13:00 UTC [Market Chatter] [Biocept Says Antonino Morales Tendered His Resignation As Company's President And Chief Executive Officer Effective On October 13, 2023; Assets Of Company Will Be Liquidated And Any Claims Paid In Accordance With Code](https://www.quantisnow.com/insight/biocept-says-antonino-morales-tendered-his-resignation-as-companys-president-5021071) - 2023-10-16 12:53 UTC [SEC Form 8-K] [Biocept Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update](https://www.quantisnow.com/insight/biocept-inc-filed-sec-form-8-k-bankruptcy-or-receivership-leadership-5021028) - 2023-10-12 16:55 UTC [Market Insight] [Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-inmode-shares-are-trading-lower-by-20-here-are-5017245) - 2023-10-12 13:29 UTC [Market Insight] [Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-bsquare-shares-are-trading-higher-by-around-44-here-5016886) - 2023-09-21 12:21 UTC [Market Chatter] [Enrollment Completed In The Feasibility Phase Of The FORESEE Clinical Trial With Biocept's CNSide Assay To Evaluate Patients With Leptomeningeal Metastases](https://www.quantisnow.com/insight/enrollment-completed-in-the-feasibility-phase-of-the-foresee-clinical-4981817) - 2023-09-21 12:00 UTC [Leadership Update] [Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases](https://www.quantisnow.com/insight/enrollment-completed-in-the-feasibility-phase-of-the-foresee-clinical-4981710) - 2023-09-08 18:57 UTC [Market Insight] [Crude Oil Moves Higher; Kroger Earnings Beat Estimates](https://www.quantisnow.com/insight/crude-oil-moves-higher-kroger-earnings-beat-estimates-4961599) - 2023-09-08 17:56 UTC [Market Insight] [Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session](https://www.quantisnow.com/insight/why-hooker-furnishings-are-trading-lower-by-15-here-are-4961530) - 2023-09-08 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-intraday-session-4961491) - 2023-09-08 16:02 UTC [Market Insight] [Dow Gains 100 Points; US Wholesale Inventories Fall In July](https://www.quantisnow.com/insight/dow-gains-100-points-us-wholesale-inventories-fall-in-july-4961334) - 2023-09-08 14:03 UTC [Market Insight] [US Stocks Mostly Higher; RH Posts Upbeat Earnings](https://www.quantisnow.com/insight/us-stocks-mostly-higher-rh-posts-upbeat-earnings-4961088) - 2023-09-08 13:18 UTC [Market Insight] [Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?](https://www.quantisnow.com/insight/why-is-cancer-diagnostic-focused-biocept-stock-trading-higher-today-4960994) - 2023-09-08 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-4960973) - 2023-09-08 12:38 UTC [Market Insight] [Market-Moving News for September 8th](https://www.quantisnow.com/insight/market-moving-news-for-september-8th-4960879) - 2023-09-08 12:36 UTC [Market Chatter] [Biocept shares are trading higher after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.](https://www.quantisnow.com/insight/biocept-shares-are-trading-higher-after-the-company-announced-non-exclusive-4960877) - 2023-09-08 12:00 UTC [Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics](https://www.quantisnow.com/insight/biocept-signs-cnside-licensing-agreement-with-plus-therapeutics-4960758) - 2023-09-08 10:30 UTC [Market Insight] [EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers](https://www.quantisnow.com/insight/exclusive-cancer-firm-plus-therapeutics-licenses-diagnostic-assay-to-detect-4960601) - 2023-09-05 12:00 UTC [Conference Announcement] [Biocept to Participate in the H.C. Wainwright Global Investment Conference](https://www.quantisnow.com/insight/biocept-to-participate-in-the-hc-wainwright-global-investment-conference-4951654) - 2023-08-25 12:00 UTC [Earnings Date] [Biocept to Hold Business Update Conference Call on August 30, 2023](https://www.quantisnow.com/insight/biocept-to-hold-business-update-conference-call-on-august-30-4937914) - 2023-08-22 20:10 UTC [SEC Form 8-K] [Biocept Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/biocept-inc-filed-sec-form-8-k-results-of-operations-and-4928827) - 2023-08-14 21:15 UTC [Market Insight] [Biocept's CNSide Cerebrospinal Fluid Assay Featured in Two Oral Presentations At The 2023 SNO/ASCO CNS Cancer Conference](https://www.quantisnow.com/insight/biocepts-cnside-cerebrospinal-fluid-assay-featured-in-two-oral-presentations-4896248) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BIOC - Earnings history: https://www.quantisnow.com/earnings/BIOC - Dividend history: https://www.quantisnow.com/dividends/BIOC - Insider transactions: https://www.quantisnow.com/insiders/BIOC - Options chain: https://www.quantisnow.com/options/BIOC - SEC 8-K filings only: https://www.quantisnow.com/company/BIOC/8-k - RSS and alerts for BIOC: https://www.quantisnow.com/docs/rss-feeds.md